title: Sodium clodronate in a patient with the Eisenmenger syndrome, hyperparathyroidism and multiple endocrine adenomatosis.
abstract: The use of sodium clodronate in the treatment of primary hyperparathyroidism is described. The drug successfully reduced the serum calcium but without improvement in the patients muscle and joint symptoms. It appears that mild degrees of hypercalcaemia have few clinical effects.
authors.affiliation: Department of Medicine, Regional Hospital, Cork.
authors.forename: D
authors.initials: D
authors.lastname: Hayes
authors.forename: F
authors.initials: F
authors.lastname: Condon
authors.forename: M
authors.initials: M
authors.lastname: Henry
authors.forename: M
authors.initials: M
authors.lastname: Duggan
authors.forename: T
authors.initials: T
authors.lastname: Mitchell
mesh_terms: D000236:Adenoma / Q000150:complications*; D004002:Clodronic Acid / Q000627:therapeutic use*; D004541:Eisenmenger Complex / Q000150:complications*; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications* / Q000188:drug therapy*; D008875:Middle Aged; D009377:Multiple Endocrine Neoplasia / Q000150:complications*; D010190:Pancreatic Neoplasms / Q000150:complications*; D010282:Parathyroid Neoplasms / Q000150:complications*; D010911:Pituitary Neoplasms / Q000150:complications*
chemical_list: D004002:Clodronic Acid